Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
194.13
-1.49 (-0.76%)
At close: Feb 18, 2026, 4:00 PM EST
193.66
-0.47 (-0.24%)
After-hours: Feb 18, 2026, 5:18 PM EST

Biogen Revenue

In the year 2025, Biogen had annual revenue of $9.89B with 2.22% growth. Biogen had revenue of $2.28B in the quarter ending December 31, 2025, a decrease of -7.14%.

Revenue (ttm)
$9.89B
Revenue Growth
+2.22%
P/S Ratio
2.88
Revenue / Employee
$1,318,747
Employees
7,500
Market Cap
28.49B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.89B214.70M2.22%
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 201914.38B925.00M6.88%
Dec 31, 201813.45B1.18B9.61%
Dec 31, 201712.27B825.10M7.21%
Dec 31, 201611.45B685.00M6.36%
Dec 31, 201510.76B1.06B10.93%
Dec 31, 20149.70B2.77B39.97%
Dec 31, 20136.93B1.42B25.66%
Dec 31, 20125.52B467.83M9.27%
Dec 31, 20115.05B332.21M7.04%
Dec 31, 20104.72B339.08M7.75%
Dec 31, 20094.38B279.84M6.83%
Dec 31, 20084.10B925.89M29.19%
Dec 31, 20073.17B488.57M18.21%
Dec 31, 20062.68B260.55M10.76%
Dec 31, 20052.42B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.65.01B
Pfizer62.58B
AstraZeneca58.74B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
GSK plc43.97B
Revenue Rankings